According to publisher, Market Insights of (APAC) artificial organ and bionics market, The Asia Pacific (APAC) artificial organ and bionics market is poised for explosive growth, projected to reach a staggering CAGR (Compound Annual Growth Rate) exceeding the global average. This surge is fueled by several key factors:
Rising Chronic Disease Burden: APAC grapples with a growing prevalence of chronic diseases like heart failure, kidney failure, and diabetes. In China alone, over 250 million people have diabetes, creating a massive demand for artificial organs like kidney transplants.
What's Inside a Bonafide Research`s industry report?
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
Aging Population: The region's rapidly aging population further intensifies the need for organ replacements and bionic implants to improve quality of life. Countries like Japan boast the highest elderly populations globally, driving demand for hip and knee replacements.
Increasing Healthcare Expenditure: Growing economies in APAC are translating into rising healthcare budgets. Governments and private players are investing heavily in advanced medical technologies, making artificial organs and bionics more accessible.
Market Dynamics
Make this report your own
Have queries/questions regarding a report
Take advantage of intelligence tailored to your business objective
Manmayi Raval
Research Consultant
The APAC market presents a unique landscape with its own set of growth drivers and challenges:
Drivers:
Technological Advancements: APAC is witnessing significant strides in bioprinting, tissue engineering, and biocompatible materials. These advancements are paving the way for more sophisticated and effective artificial organs and bionics.
Don’t pay for what you don’t need. Save 30%
Customise your report by selecting specific countries or regions
Government Initiatives: Several APAC governments are actively supporting research and development (R&D) in this field. Initiatives like China's National Key R&D Program are accelerating innovation and market growth.
Challenges:
High Costs: Artificial organs and bionics remain expensive, limiting access for a large portion of the population. This necessitates cost-effective solutions and wider insurance coverage.
Regulatory Stringency: Regulatory frameworks for these technologies are still evolving, creating hurdles for market entry. Streamlining approval processes is crucial for faster adoption.
Market Segments
The APAC market can be segmented by product, technology, and application:
Product:
Artificial Organs: Hearts, kidneys, livers, lungs, etc.
Bionics: Cochlear implants, exoskeletons, bionic limbs, etc.
Technology:
Mechanical Bionics: Implants relying on gears, levers, and motors. (e.g., prosthetic limbs)
Electronic Bionics: Implants using electronic components to interact with nerves or muscles. (e.g., cochlear implants)
Application:
The APAC market is a heterogeneous landscape with significant variations:
China: The frontrunner in the region, driven by a large patient pool, government support, and a burgeoning medical device industry.
India: A high-potential market with a large and young population. Affordability and access remain key challenges.
Japan: A mature market with a focus on advanced technologies and high-quality bionics.
South Korea: Witnessing rapid growth due to strong government backing and a focus on R&D.
Key Developments
The APAC market is witnessing a flurry of activity:
2023: A Chinese company successfully implants a brain-computer interface (BCI) in a paralyzed patient, allowing partial control of a robotic arm.
2024: An Indian startup unveils a next-generation artificial kidney for home dialysis, potentially revolutionizing patient care.
Competitive Landscape
The APAC market is a mix of established global players and emerging regional competitors:
Global Players: Abbott Laboratories, Medtronic, Siemens Healthineers, etc.
Regional Players: Terumo (Japan), Mindray (China), Dr. Reddy's Laboratories (India), etc.
Conclusion
The APAC artificial organ and bionics market is on an upward trajectory, fueled by rising healthcare needs, technological advancements, and government support. Overcoming challenges like affordability and regulations will unlock the full potential of this life-changing technology.
Table of Contents
1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the Market 23
2.1.3 Impact of Russia-Ukraine Conflict: War Slows Economic Recovery 25
2.2 Major Growth Drivers 29
2.3 Market Restraints and Challenges 33
2.4 Emerging Opportunities and Market Trends 36
2.5 Porter’s Fiver Forces Analysis 40
3 Segmentation of Asia Pacific Market by Product Type 44
3.1 Market Overview by Product Type 44
3.2 Artificial Organ 46
3.2.1 Kidney 48
3.2.2 Heart 49
3.2.3 Liver 50
3.2.4 Lungs 51
3.2.5 Pancreas 52
3.2.6 Other Organs 53
3.3 Artificial Bionics 54
3.3.1 Ear Bionics 56
3.3.2 Exoskeleton 57
3.3.3 Bionic Limbs 58
3.3.4 Vision Bionics 59
3.3.5 Brain Bionics 60
3.3.6 Cardiac Bionics 61
3.3.7 Other Bionics 62
4 Segmentation of Asia Pacific Market by Material 63
4.1 Market Overview by Material 63
4.2 Metals 65
4.3 Polymers 66
4.4 Ceramics 67
4.5 Other Materials 68
5 Segmentation of Asia Pacific Market by Technology 69
5.1 Market Overview by Technology 69
5.2 Mechanical 71
5.3 Electronic 72
6 Segmentation of Asia Pacific Market by Fixation Type 73
6.1 Market Overview by Fixation Type 73
6.2 Implantable 75
6.3 Wearable 76
7 Segmentation of Asia Pacific Market by Age Group 77
7.1 Market Overview by Age Group 77
7.2 17 Years Old and Under 79
7.3 18-34 Years Old 80
7.4 35-49 Years Old 81
7.5 50-64 Years Old 82
7.6 65 Years Old and Above 83
8 Segmentation of Asia Pacific Market by End User 84
8.1 Market Overview by End User 84
8.2 Hospitals 86
8.3 Ambulatory Surgical Centers (ASCs) 87
8.4 Other End Users 88
9 Asia-Pacific Market 2022-2032 by Country 89
9.1 Overview of Asia-Pacific Market 89
9.2 Japan 92
9.3 China 95
9.4 Australia 97
9.5 India 99
9.6 South Korea 101
9.7 Rest of APAC Region 103
10 Competitive Landscape 105
10.1 Overview of Key Vendors 105
10.2 New Product Launch, Partnership, Investment, and M&A 108
10.3 Company Profiles 109
Abbott Laboratories Inc. 109
Abiomed, Inc. 111
Berlin Heart GmbH 112
Biomet Inc. 113
Boston Scientific Corporation 114
Cochlear Ltd. 115
Edward Lifesciences Corporation 116
Ekso Bionics Holdings, Inc. 117
Iwalk Inc. 118
Jarvik Heart, Inc. 119
Medtronic Plc 120
Össur hf. 121
ReWalk Robotics Ltd. 122
SynCardia Systems LLC 123
Zimmer Biomet Holdings Inc. 124
RELATED REPORTS 125
Table 1. Snapshot of Asia Pacific Artificial Organ and Bionics Market in Balanced Perspective, 2022-2032 17
Table 2. World Economic Outlook, 2021-2031 21
Table 3. World Economic Outlook, 2021-2023 22
Table 4. Scenarios for Economic Impact of Ukraine Crisis 26
Table 5. Main Product Trends and Market Opportunities in Asia Pacific Artificial Organ and Bionics Market 36
Table 6. Asia Pacific Artificial Organ and Bionics Market by Product Type, 2022-2032, $ mn 44
Table 7. Asia Pacific Artificial Organ and Bionics Market: Artificial Organ by Type, 2022-2032, $ mn 47
Table 8. Asia Pacific Artificial Organ and Bionics Market: Artificial Bionics by Type, 2022-2032, $ mn 55
Table 9. Asia Pacific Artificial Organ and Bionics Market by Material, 2022-2032, $ mn 63
Table 10. Asia Pacific Artificial Organ and Bionics Market by Technology, 2022-2032, $ mn 69
Table 11. Asia Pacific Artificial Organ and Bionics Market by Fixation Type, 2022-2032, $ mn 73
Table 12. Asia Pacific Artificial Organ and Bionics Market by Age Group, 2022-2032, $ mn 77
Table 13. Asia Pacific Artificial Organ and Bionics Market by End User, 2022-2032, $ mn 84
Table 14. APAC Artificial Organ and Bionics Market by Country, 2022-2032, $ mn 90
Table 15. Japan Artificial Organ and Bionics Market by Product Type, 2022-2032, $ mn 94
Table 16. Japan Artificial Organ and Bionics Market by Technology, 2022-2032, $ mn 94
Table 17. Japan Artificial Organ and Bionics Market by End User, 2022-2032, $ mn 94
Table 18. China Artificial Organ and Bionics Market by Product Type, 2022-2032, $ mn 96
Table 19. China Artificial Organ and Bionics Market by Technology, 2022-2032, $ mn 96
Table 20. China Artificial Organ and Bionics Market by End User, 2022-2032, $ mn 96
Table 21. Australia Artificial Organ and Bionics Market by Product Type, 2022-2032, $ mn 98
Table 22. Australia Artificial Organ and Bionics Market by Technology, 2022-2032, $ mn 98
Table 23. Australia Artificial Organ and Bionics Market by End User, 2022-2032, $ mn 98
Table 24. India Artificial Organ and Bionics Market by Product Type, 2022-2032, $ mn 100
Table 25. India Artificial Organ and Bionics Market by Technology, 2022-2032, $ mn 100
Table 26. India Artificial Organ and Bionics Market by End User, 2022-2032, $ mn 100
Table 27. South Korea Artificial Organ and Bionics Market by Product Type, 2022-2032, $ mn 102
Table 28. South Korea Artificial Organ and Bionics Market by Technology, 2022-2032, $ mn 102
Table 29. South Korea Artificial Organ and Bionics Market by End User, 2022-2032, $ mn 102
Table 30. Artificial Organ and Bionics Market in Rest of APAC by Country/Region, 2022-2032, $ mn 104
Table 31. Abbott Laboratories Inc.: Company Snapshot 109
Table 32. Abbott Laboratories Inc.: Business Segmentation 110
Table 33. Abbott Laboratories Inc.: Product Portfolio 110
Figure 1. Research Method Flow Chart 11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2022-2032 16
Figure 4. Asia Pacific Artificial Organ and Bionics Market, 2022-2032, $ mn 19
Figure 5. Impact of COVID-19 on Business 23
Figure 6. Primary Drivers and Impact Factors of Asia Pacific Artificial Organ and Bionics Market 29
Figure 7. Overview of Worldwide Organ Donation and Transplant, 2021 32
Figure 8. Estimated Number of Worldwide Organ Transplants by Organ Type in 2021 32
Figure 9. Primary Restraints and Impact Factors of Asia Pacific Artificial Organ and Bionics Market 33
Figure 10. Investment Opportunity Analysis 37
Figure 11. Porter’s Fiver Forces Analysis of Asia Pacific Artificial Organ and Bionics Market 40
Figure 12. Breakdown of Asia Pacific Artificial Organ and Bionics Market by Product Type, 2022-2032, % of Revenue 45
Figure 13. Asia Pacific Addressable Market Cap in 2023-2032 by Product Type, Value ($ mn) and Share (%) 45
Figure 14. Asia Pacific Artificial Organ and Bionics Market by Product Type: Artificial Organ, 2022-2032, $ mn 46
Figure 15. Asia Pacific Artificial Organ and Bionics Market by Artificial Organ: Kidney, 2022-2032, $ mn 48
Figure 16. Asia Pacific Artificial Organ and Bionics Market by Artificial Organ: Heart, 2022-2032, $ mn 49
Figure 17. Asia Pacific Artificial Organ and Bionics Market by Artificial Organ: Liver, 2022-2032, $ mn 50
Figure 18. Asia Pacific Artificial Organ and Bionics Market by Artificial Organ: Lungs, 2022-2032, $ mn 51
Figure 19. Asia Pacific Artificial Organ and Bionics Market by Artificial Organ: Pancreas, 2022-2032, $ mn 52
Figure 20. Asia Pacific Artificial Organ and Bionics Market by Artificial Organ: Other Organs, 2022-2032, $ mn 53
Figure 21. Asia Pacific Artificial Organ and Bionics Market by Product Type: Artificial Bionics, 2022-2032, $ mn 54
Figure 22. Asia Pacific Artificial Organ and Bionics Market by Artificial Bionics: Ear Bionics, 2022-2032, $ mn 56
Figure 23. Asia Pacific Artificial Organ and Bionics Market by Artificial Bionics: Exoskeleton, 2022-2032, $ mn 57
Figure 24. Asia Pacific Artificial Organ and Bionics Market by Artificial Bionics: Bionic Limbs, 2022-2032, $ mn 58
Figure 25. Asia Pacific Artificial Organ and Bionics Market by Artificial Bionics: Vision Bionics, 2022-2032, $ mn 59
Figure 26. Asia Pacific Artificial Organ and Bionics Market by Artificial Bionics: Brain Bionics, 2022-2032, $ mn 60
Figure 27. Asia Pacific Artificial Organ and Bionics Market by Artificial Bionics: Cardiac Bionics, 2022-2032, $ mn 61
Figure 28. Asia Pacific Artificial Organ and Bionics Market by Artificial Bionics: Other Bionics, 2022-2032, $ mn 62
Figure 29. Breakdown of Asia Pacific Artificial Organ and Bionics Market by Material, 2022-2032, % of Sales Revenue 64
Figure 30. Asia Pacific Addressable Market Cap in 2023-2032 by Material, Value ($ mn) and Share (%) 64
Figure 31. Asia Pacific Artificial Organ and Bionics Market by Material: Metals, 2022-2032, $ mn 65
Figure 32. Asia Pacific Artificial Organ and Bionics Market by Material: Polymers, 2022-2032, $ mn 66
Figure 33. Asia Pacific Artificial Organ and Bionics Market by Material: Ceramics, 2022-2032, $ mn 67
Figure 34. Asia Pacific Artificial Organ and Bionics Market by Material: Other Materials, 2022-2032, $ mn 68
Figure 35. Breakdown of Asia Pacific Artificial Organ and Bionics Market by Technology, 2022-2032, % of Sales Revenue 70
Figure 36. Asia Pacific Addressable Market Cap in 2023-2032 by Technology, Value ($ mn) and Share (%) 70
Figure 37. Asia Pacific Artificial Organ and Bionics Market by Technology: Mechanical, 2022-2032, $ mn 71
Figure 38. Asia Pacific Artificial Organ and Bionics Market by Technology: Electronic, 2022-2032, $ mn 72
Figure 39. Breakdown of Asia Pacific Artificial Organ and Bionics Market by Fixation Type, 2022-2032, % of Revenue 74
Figure 40. Asia Pacific Addressable Market Cap in 2023-2032 by Fixation Type, Value ($ mn) and Share (%) 74
Figure 41. Asia Pacific Artificial Organ and Bionics Market by Fixation Type: Implantable, 2022-2032, $ mn 75
Figure 42. Asia Pacific Artificial Organ and Bionics Market by Fixation Type: Wearable, 2022-2032, $ mn 76
Figure 43. Breakdown of Asia Pacific Artificial Organ and Bionics Market by Age Group, 2022-2032, % of Revenue 78
Figure 44. Asia Pacific Addressable Market Cap in 2023-2032 by Age Group, Value ($ mn) and Share (%) 78
Figure 45. Asia Pacific Artificial Organ and Bionics Market by Age Group: 17 Years Old and Under, 2022-2032, $ mn 79
Figure 46. Asia Pacific Artificial Organ and Bionics Market by Age Group: 18-34 Years Old, 2022-2032, $ mn 80
Figure 47. Asia Pacific Artificial Organ and Bionics Market by Age Group: 35-49 Years Old, 2022-2032, $ mn 81
Figure 48. Asia Pacific Artificial Organ and Bionics Market by Age Group: 50-64 Years Old, 2022-2032, $ mn 82
Figure 49. Asia Pacific Artificial Organ and Bionics Market by Age Group: 65 Years Old and Above, 2022-2032, $ mn 83
Figure 50. Breakdown of Asia Pacific Artificial Organ and Bionics Market by End User, 2022-2032, % of Revenue 84
Figure 51. Asia Pacific Addressable Market Cap in 2023-2032 by End User, Value ($ mn) and Share (%) 85
Figure 52. Asia Pacific Artificial Organ and Bionics Market by End User: Hospitals, 2022-2032, $ mn 86
Figure 53. Asia Pacific Artificial Organ and Bionics Market by End User: Ambulatory Surgical Centers (ASCs), 2022-2032, $ mn 87
Figure 54. Asia Pacific Artificial Organ and Bionics Market by End User: Other End Users, 2022-2032, $ mn 88
Figure 55. Breakdown of APAC Artificial Organ and Bionics Market by Country, 2022 and 2032, % of Revenue 90
Figure 56. Contribution to APAC 2023-2032 Cumulative Market by Country, Value ($ mn) and Share (%) 91
Figure 57. Artificial Organ and Bionics Market in Japan, 2022-2032, $ mn 93
Figure 58. Artificial Organ and Bionics Market in China, 2022-2032, $ mn 95
Figure 59. Artificial Organ and Bionics Market in Australia, 2022-2032, $ mn 97
Figure 60. Artificial Organ and Bionics Market in India, 2022-2032, $ mn 99
Figure 61. Artificial Organ and Bionics Market in South Korea, 2022-2032, $ mn 101
Figure 62. Artificial Organ and Bionics Market in Rest of APAC, 2022-2032, $ mn 103
Figure 63. Growth Stage of Asia Pacific Artificial Organ and Bionics Industry over the Forecast Period 105
One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. Read More
One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. Read More
Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. Read More
All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). Read More